What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series
Gandaglia, Giorgio, M.D, Ploussard, Guillaume, M.D, Isbarn, Hendrik, M.D, Suardi, Nazareno, M.D, De Visschere, Peter J.L., M.D, Futterer, Jurgen J., M.D, Ghadjar, Pirus, M.D, Massard, Christophe, M.D, Ost, Piet, M.D, Sooriakumaran, Prasanna, M.D, Surcel, Christian I., M.D, van den Bergh, Roderick C.N., M.D, Montorsi, Francesco, M.D, Ficarra, Vincenzo, M.D, Giannarini, Gianluca, M.D, Briganti, Alberto, M.D
Published in Urologic oncology (01.04.2015)
Published in Urologic oncology (01.04.2015)
Get full text
Journal Article
Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review
Surcel, Cristian I., M.D., Ph.D, van Oort, Inge M., M.D., Ph.D, Sooriakumaran, Prasanna, M.D., Ph.D, Briganti, Alberto, M.D., Ph.D, De Visschere, Peter J.L., M.D, Fütterer, Jurgen J., M.D, Ghadjar, Pirus, M.D., Ph.D, Isbarn, Hendrik, M.D., Ph.D, Ost, Piet, M.D., Ph.D, van den Bergh, Roderick C.N., M.D., Ph.D, Yossepowitch, Ofer, M.D., Ph.D, Giannarini, Gianluca, M.D, Ploussard, Guillaume, MD, PhD
Published in Urologic oncology (01.06.2015)
Published in Urologic oncology (01.06.2015)
Get full text
Journal Article